Ole Torffvit (Former)
11 – 20 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Tamm-Horsfall protein gene is associated with distal tubular dysfunction in patients with type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension
(
- Contribution to journal › Article
-
Mark
The response to antihypertensive therapy is dependent on renal structural changes. A 5-year prospective study of renal biopsy in type 2 diabetic patients with micro-macroalbuminuria.
(
- Contribution to journal › Article
- 2009
-
Mark
Swedish patients with type 2 diabetes show willingness-to-pay for health improvements including weight loss, reduction in hypoglycaemia and glycaemic control
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52. p.1039-1039(
- Contribution to journal › Published meeting abstract
-
Mark
Urinary transforming growth factor-1, collagen IV and the effect of insulin in children at diagnosis of diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Patient willingness-to-pay for liraglutide and exenatide in Sweden based on head-to-head clinical trial results
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52. p.1040-1040(
- Contribution to journal › Published meeting abstract
-
Mark
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
(
- Contribution to journal › Article
-
Mark
Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy.
(
- Contribution to journal › Article
- 2008
-
Mark
Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients.
(
- Contribution to journal › Article